Skip to content

A Randomized, Controlled, Double-blind, Multicenter Clinical Study of the Electroacupuncture Treatment on Muscle and Bone Balance of Knee Osteoarthritis

A Randomized, Controlled, Double-blind, Multicenter Clinical Study of the Electroacupuncture Treatment on Muscle and Bone Balance of Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003638
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Experimental Comparator treatment:meridian electroacupunctureAcupuncture treatment will be the Traditional Chinese Medicine type(Liangqiu acupoint,Futu acupoint,Xiyan acupoint,Dubi acupoint). Acupunct
Active Comparator:Acupuncture treatment will be the Traditional Chinese Medicine type(Xuehai acupoint,Liangqiu acupoint,Ququan acupoint, Xiyangguan acupoint,Zusanli acupoint,Yinlingquan acupoint,Sanyi
control group:False Needle treatment will be modeled the Traditional Chinese Medicine type. (Xuehai acupoint,Liangqiu acupoint,Ququan acupoint, Xiyangguan acupoint,Zusanli acupoint,Yinlingquan acupoin

Sponsors

Shanghai Longhua Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the western medicine diagnostic criteria of knee osteoarthritis; 2. Aged between 50 and 75 years; 3. Patients in line the level of radiological classification for knee osteoarthritis degeneration; 4. Patients who did not use glucocorticoid via oral administration or intramuscular, articular, or soft tissue injection four weeks before accepting the test agent; 5. Patients who signed the informed consent and ensured the compliance.

Exclusion criteria

Exclusion criteria: 1. Patients with long-term oral administration of agents for knee osteoarthritis, and still in the drug effect period, without elution; 2. Patients with severe heart, brain, liver, kidney or lung dysfunction; 3. Patients with other knee diseases found in arthroscopic surgery; 4. Patients who have accepted other relevant treatments, which may affect the observation on the effects of this study; 5. Patients with mental illness; 6. Patients with coagulation dysfunction; 7. Patients with articular surgical treatment; 8. Patients with an indication for joint surgery 9. Patients with a history of abuse of opioid analgesics, sedative hypnotics or alcohol; 10. Patients with poor compliance, who were unable to meet the requirements for follow-up. 11. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Lequesne index;VAS score;Six-minute walking test;WOMAC;The Medical Outcomes Study short form health survey-36;

Secondary

MeasureTime frame
Ultrasound of the knee joint;3D Gait Analysis;Proteome resequencing: peripheral blood.;Isometric muscle strength test;Knee CT;NIR-ICG near-infrared detection;inguinal lymph node ultrasound;

Countries

China

Contacts

Public ContactWang Yongjun

Shanghai Longhua Hospital

Yjwang8888@126.com+86 18917763018

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026